Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003
- 240 Downloads
The prescription pattern of statins in the Local Health Unit (LHU) of Treviso (northern Italy) over a 10-year period was evaluated, with the aim of evaluating the persistence with and adherence to therapy.
Data on 21,393 subjects who received at least one prescription for statins during the period between January 1, 1994 and December 31, 2003 were retrieved from the LHU database in order to track the pharmacological history of individual patients. The data included age, sex, drug formulation, strength, number of drug packages prescribed, and prescription date. The adopted indicators for drug utilization included the Defined Daily Dose (DDD), the Received Daily Dose (RDD), and a surrogated Prescribed Daily Dose (sPDD), extrapolated from available prescription data. An Adherence to Therapy Index (ATI) was calculated from the ratio between the amount of drug actually prescribed and the amount of sPDD. Based on the ATI, patients were grouped into non-adherent, poor-adherent, and good-adherent groups. The distribution of adherence level among patient-age classes and statin-prescribed patients in primary or secondary prevention was evaluated.
All drug-utilization indicators showed an increase in statin use over the study period in terms of both the number of prescribed patients and the sPDD. Persistence with and adherence to therapy remained low, with a 50% discontinuation rate in the first year, and persistent patients did not follow the therapy regularly. Patients in secondary prevention were the most adherent to their drug regimen, although only 41% of these had a good compliance.
Our findings suggest an increase in statin use which is, however, accompanied by poor patient persistence with and adherence to statin therapy.
KeywordsAdherence to Therapy (ATI) DDD Drug utilization Persistence with therapy Statins
The authors thank Dr. Ennio Scaldaferri and Dr. Silvia Chiroli for their helpful comments on the paper. This study has been supported by a Grant from Regione Veneto. DRG n. 4034, December, 20, 2005.
- 6.Ministero della Salute (2003) L’uso dei farmaci in Italia: rapporto nazionale anno 2003. Il Pensiero Scientifico Editore, Rome, pp 82–86Google Scholar
- 7.World Health Organization Collaborating Centre for Drug Statistics Methodology (2000) ATC Index with DDDs. WHO, OsloGoogle Scholar
- 9.Genest J, Frohlich J, Fodor G, McPherson R, Working Group on Hypercholesterolemia and Other Dyslipidemias (2003) Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Can Med Assoc J 169:921–924Google Scholar
- 10.De Ambrosis P, Saramin C, Terrazzani G, Scaldaferri E, Giusti P, Chinellato A (2005) Ten years of statin utilization: adherence to therapy and cost of treatment. Pharmacoeconomics 7:187–194Google Scholar
- 11.Chinellato A, Terrazzani G, Debetto P, Zambon P, Guzzinati S, Walley T, Giusti P (2006) Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region. Br J Clin Pharmacol 62:130–133Google Scholar
- 13.Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists’ (CTT) Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267–1278PubMedCrossRefGoogle Scholar